{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:51:37Z","timestamp":1782305497068,"version":"3.54.5"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["294738"],"award-info":[{"award-number":["294738"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Inflammation Center of Helsinki University Hospital"},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Research Funding of OUH"},{"DOI":"10.13039\/501100006432","name":"University of Oulu Graduate School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006432","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010746","name":"Finnish Dermatological Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010746","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finnish Society of Dermatopathology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,17]]},"abstract":"<jats:p>Bullous pemphigoid (BP) is the most common autoimmune blistering skin disease, which typically affects the elderly and causes an increased risk for death. This retrospective study of data from electronic health records of two Finnish university hospitals showed that treatment with methotrexate was associated with a significantly reduced mortality of patients with BP compared with those treated with other drugs. In addition, we found that advanced age at diagnosis, concomitant type 2 diabetes, dementia and mean value of circulating BP180 antibodies \u2265 60\u2005U mL\u20131 were predictors for a poor outcome.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf172","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T07:48:24Z","timestamp":1746431304000},"page":"345-347","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of bullous pemphigoid with methotrexate is associated with a decreased mortality risk"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5655-8079","authenticated-orcid":false,"given":"P\u00e4ivi","family":"Leisti","sequence":"first","affiliation":[{"name":"Department of Dermatology, Research Unit of Clinical Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu , Oulu ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7182-5892","authenticated-orcid":false,"given":"Anna","family":"Pankakoski","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital , Helsinki ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7597-4323","authenticated-orcid":false,"given":"Laura","family":"Huilaja","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Research Unit of Clinical Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu , Oulu ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4629-0560","authenticated-orcid":false,"given":"Jari","family":"Jokelainen","sequence":"additional","affiliation":[{"name":"Northern Finland Birth Cohorts, Arctic Biobank and Infrastructure for Population Studies, University of Oulu , Oulu ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-2611","authenticated-orcid":false,"given":"Outi","family":"Varpuluoma","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Research Unit of Clinical Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu , Oulu ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5733-2848","authenticated-orcid":false,"given":"Jaana","family":"Panelius","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital , Helsinki ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8056-5949","authenticated-orcid":false,"given":"Kaisa","family":"Tasanen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Research Unit of Clinical Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu , Oulu ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"2025071703165093400_ljaf172-B1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jdv.18220","article-title":"Updated S2\u2005K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"2025071703165093400_ljaf172-B2","doi-asserted-by":"crossref","first-page":"e0264705","DOI":"10.1371\/journal.pone.0264705","article-title":"Prognostic factors for mortality in bullous pemphigoid: a systematic review and meta-analysis","volume":"17","author":"Chen","year":"2022","journal-title":"PLoS One"},{"key":"2025071703165093400_ljaf172-B3","doi-asserted-by":"crossref","first-page":"1281302","DOI":"10.3389\/fimmu.2023.1281302","article-title":"Accurate diagnosis of bullous pemphigoid requires multiple health care visits","volume":"14","author":"Leisti","year":"2023","journal-title":"Front Immunol"},{"key":"2025071703165093400_ljaf172-B4","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/jdv.16363","article-title":"Anti-BP180 autoantibody levels at diagnosis correlate with 1-year mortality rates in patients with bullous pemphigoid","volume":"34","author":"Monshi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025071703165093400_ljaf172-B5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archderm.144.5.612","article-title":"A retrospective analysis of patients with bullous pemphigoid treated with methotrexate","volume":"144","author":"Kjellman","year":"2008","journal-title":"Arch Dermatol"},{"key":"2025071703165093400_ljaf172-B6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1684\/ejd.2019.3501","article-title":"Methotrexate is safe and effective as long-term treatment for bullous pemphigoid","volume":"29","author":"Delaumenie","year":"2019","journal-title":"Eur J Dermatol"},{"key":"2025071703165093400_ljaf172-B7","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1365-2133.2011.10531.x","article-title":"Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study","volume":"165","author":"Du-Thanh","year":"2011","journal-title":"Br J Dermatol"},{"key":"2025071703165093400_ljaf172-B8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jaad.2020.01.084","article-title":"Low-dose methotrexate use and safety for older patients with bullous pemphigoid and impaired renal function: a cohort study","volume":"82","author":"Fisch","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf172\/63054213\/ljaf172.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/2\/345\/63054213\/ljaf172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/2\/345\/63054213\/ljaf172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T07:16:57Z","timestamp":1752736617000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/193\/2\/345\/8124951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":8,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,5,5]]},"published-print":{"date-parts":[[2025,7,17]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf172","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,5,5]]}}}